Transcervical resection of submucous fibroid reduces menstrual blood loss: EJOG
Written By : Dr Nirali Kapoor
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2022-08-02 15:00 GMT | Update On 2022-08-02 15:01 GMT
Advertisement
Uterine fibroids are very common, affecting >60% of women aged 45 and older. Submucous fibroids can cause heavy menstrual bleeding (HMB), dysmenorrhea and fertility problems. Transcervical resection of myoma (TCRM) is a widely implemented treatment, in particular for FIGO PALM-COEIN classification type 0, 1 and 2 fibroids. TCRM seems to be safe and effective for reducing HMB in qualitative studies, with only a small percentage of patients needing repeat surgery (approximately 4% after 2–3 years and < 10% after 5 years).
Furthermore, HMB can cause anemia and iron deficiency. The presence of submucous fibroids and the amount of protrusion is also related to anemia and (lower) Hb level, although no significant relation to Pictorial Blood Assessment Chart (PBAC) score and anemia or Hb level was found. PBAC is a validated measurement instrument to quantify menstrual blood loss, where women score the number of pads or tampons used during their period and the degree to which those were stained with blood. A PBAC score of > 150 indicates HMB. The uterine fibroid symptom and quality of life questionnaire (UFSQOL) was developed for assessing (other) fibroid related symptoms and health related quality of life in women with uterine fibroids. UFSQOL scores have been reported to improve after TCRM.
The aim of this study by A.L. Keizer et al was to quantify the effect of TCRM on HMB and health-related quality of life in patients with submucous fibroids, using PBAC, UFS-QOL and Hb level. In women with submucous fibroids, HMB measured by PBAC decreased significantly 6 months after TCRM compared to baseline. Symptom severity scores were significantly lower and health related quality of life scores were higher 6 months after TCRM.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.